--- SEARCH ---
WEATHER
CHINA
INTERNATIONAL
BUSINESS
CULTURE
GOVERNMENT
SCI-TECH
ENVIRONMENT
LIFE
PEOPLE
TRAVEL
THIS WEEK
Learning Chinese
Learn to Cook Chinese Dishes
Exchange Rates


Hot Links
China Development Gateway
Chinese Embassies

Chinese Bio-tech Company Works on SARS Vaccines
The China National Biological Products Corporation (CNBPC), the largest bio-tech company in China, plans to spend 500 million yuan (US$60.46 million) developing vaccines against severe acute respiratory syndrome (SARS).

The first 50 million yuan has been invested in the early stage of the project, Wang Guoli, general manager with the CNBPC, said Monday.

The money will be spent in improving and rebuilding lab and production facilities for SARS vaccines, flu vaccines, blood products and other biological products, Wang said.

The company is carrying out three SARS-related research projects and has invested another 10 million yuan in developing SARS detecting methods, blood serums against SARS and relevant vaccines.

The CNBPC, founded in 1989 as the country's leading vaccine manufacturer, produces more than 50 kinds of vaccines.

The company is made up of six national research institutes on biological products in Chinese cities of Beijing, Changchun, Chengdu and Lanzhou.

(Xinhua News Agency June 10, 2003)

Further Developments in Push for SARS Vaccine
SARS Vaccine Set for Animal Testing
Chinese Scientists Make New Breakthrough in SARS Vaccine Research
Joint Efforts Underway for Development of SARS Vaccine
SARS Vaccine Likely in Months: Chinese Experts
Canada Lab's SARS Gene to Speed Vaccine--Researchers
US Scientist Sees Vaccine for Pigs as Clue to Fighting SARS
SARS
Print This Page
|
Email This Page
About Us SiteMap Feedback
Copyright © China Internet Information Center. All Rights Reserved
E-mail: webmaster@china.org.cn Tel: 86-10-68326688